Home Cart Sign in  
Chemical Structure| 189261-10-7 Chemical Structure| 189261-10-7

Structure of Natalizumab
CAS No.: 189261-10-7

Chemical Structure| 189261-10-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Natalizumab is a humanized IgG4 monoclonal antibody that prevents ITGA4 from binding to its ligand. Natalizumab has potential for multiple sclerosis and Crohn's disease research.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Natalizumab

CAS No. :189261-10-7
M.W : 146.22 kDa
SMILES Code : NONE

Safety of Natalizumab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Natalizumab

cytoskeleton

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00297232 Relapsing-Remitting Multiple S... More >>clerosis Less << PHASE3 TERMINATED 2025-04-14 Research Site, Camperdown, 205... More >>0, Australia|Research Site, Heidelberg, 3084, Australia|Research Site, Parkville, 3050, Australia|Research Site, Brugge, 8000, Belgium|Research Site, Brussels, 1070, Belgium|Research Site, Charleroi, 6000, Belgium|Research Site, Diepenbeek, 3590, Belgium|Research Site, Melsbroek, 1820, Belgium|Research Site, Sijsele, 8340, Belgium|Research Site, Vancouver, British Columbia, V6T 2B5, Canada|Research Site, Halifax, Nova Scotia, B3H IV7, Canada|Research Site, Kingston, Ontario, K7L 2V7, Canada|Research Site, London, Ontario, N6A5A5, Canada|Research Site, New York, Ontario, M4N 3M5, Canada|Research Site, Ottawa, Ontario, K2G6E2, Canada|Research Site, Toronto, Ontario, M5B 1W8, Canada|Research Site, Gatineau, Quebec, J8Y 1W7, Canada|Research Site, Greenfield Park, Quebec, J4V 2H1, Canada|Research Site, Montreal, Quebec, H3A2B4, Canada|Research Site, Brno, 625 00, Czech Republic|Research Site, Brno, 656 91, Czech Republic|Research Site, Hradec Kralove, 500 05, Czech Republic|Research Site, Olomouc, 775 20, Czech Republic|Research Site, Ostrava, 708 52, Czech Republic|Research Site, Pardubice, 532 03, Czech Republic|Research Site, Plzen, 323 00, Czech Republic|Research Site, Praha 2, 12000, Czech Republic|Research Site, Praha 5, 150 06, Czech Republic|Research Site, Aarhus C, 8000, Denmark|Research Site, Esbjerg, 6700, Denmark|Research Site, Kobenhavn, 2100, Denmark|Research Site, Helsinki, 00290, Finland|Research Site, Tampere, 33520, Finland|Research Site, Turku, 20100, Finland|Research Site, Besancon, 25030, France|Research Site, Bordeaux, 33076, France|Research Site, Clermont-Ferrand, 63003, France|Research Site, Creteil, 94101, France|Research Site, Dijon, 21033, France|Research Site, Lille, 59037, France|Research Site, Lyon, 69677, France|Research Site, Marseille, 13385, France|Research Site, Nancy, 54035, France|Research Site, Paris, 75019, France|Research Site, Paris, 75651, France|Research Site, Rennes, 35033, France|Research Site, Strasbourg, 67091, France|Research Site, Toulouse, 31059, France|Research Site, Berlin, 13347, Germany|Research Site, Essen, 45122, Germany|Research Site, Gie?en, 35385, Germany|Research Site, Hannover, 30625, Germany|Research Site, Hennigsdorf, 16761, Germany|Research Site, München, 81377, Germany|Research Site, Offenbach, 63069, Germany|Research Site, Osnabrück, 49076, Germany|Research Site, Regensburg, 93053, Germany|Research Site, Rostock, 18147, Germany|Research Site, Athens, 11527, Greece|Research Site, Budapest, 1021, Hungary|Research Site, Budapest, 1115, Hungary|Research Site, Budapest, 1145, Hungary|Research Site, Budapest, 1204, Hungary|Research Site, Debrecen, 4012, Hungary|Research Site, Debrecen, 4031, Hungary|Research Site, Gyor, 9000, Hungary|Research Site, Nyiregyhaza, 4400, Hungary|Research Site, Szekesfehervar, 8000, Hungary|Research Site, Dublin, 4, Ireland|Research Site, Jerusalem, 91120, Israel|Research Site, Tel Hashomer, 52621, Israel|Research Site, Bari, 70124, Italy|Research Site, Genova, 16132, Italy|Research Site, Milano, 20132, Italy|Research Site, Roma, 00185, Italy|Research Site, Amsterdam, 1081HV, Netherlands|Research Site, Breda, 4818 CK, Netherlands|Research Site, Hertogenbosch, 5211 NL, Netherlands|Research Site, Nieuwegein, 3435 CM, Netherlands|Research Site, Nijmegen, 6533 PA, Netherlands|Research Site, Rotterdam, 3015 GD, Netherlands|Research Site, Auckland, 1023, New Zealand|Research Site, Christchurch, 8011, New Zealand|Research Site, Bia?ystok, 15-402, Poland|Research Site, Bia?ystok, 15-420, Poland|Research Site, Bydgoszcz, 85-681, Poland|Research Site, Gdańsk, 80-803, Poland|Research Site, Katowice, 40-752, Poland|Research Site, Kraków, 31-530, Poland|Research Site, Lodz, 90-153, Poland|Research Site, Lublin, 20-954, Poland|Research Site, Warsaw, 02-957, Poland|Research Site, Warszawa, 02-097, Poland|Research Site, Barcelona, 08035, Spain|Research Site, Barcelona, 08907, Spain|Research Site, Málaga, 29010, Spain|Research Site, Goteborg, 41685, Sweden|Research Site, Stockholm, 141 86, Sweden|Research Site, Stockholm, 17176, Sweden|Research Site, Basel, 4031, Switzerland|Research Site, Ankara, 06100, Turkey|Research Site, Istanbul, 34303, Turkey|Research Site, Istanbul, 34390, Turkey|Research Site, Essex, RM7 0AG, United Kingdom|Research Site, Liverpool, L9 7AJ, United Kingdom|Research Site, London, E1 1BB, United Kingdom|Research Site, London, SE5 9RF, United Kingdom|Research Site, London, SW17 0QT, United Kingdom|Research Site, Newcastle Upon Tyne, NE14LP, United Kingdom|Research Site, Oxford, OX3 9DU, United Kingdom|Research Site, Sheffield, S10 2JF, United Kingdom|Research Site, Stoke on Trent, ST4 7LN, United Kingdom Less <<
NCT05701423 Multiple Sclerosis TERMINATED 2024-07-31 Klinik für Neurologie, Univers... More >>it?tsklinikum Düsseldorf, Düsseldorf, 40225, Germany Less <<
NCT02483845 Inclusion Body Myositis (IBM) PHASE1 UNKNOWN 2025-11-17 Phoenix Neurological Insitutut... More >>e, Phoenix, Arizona, 85018, United States Less <<
NCT03046251 Multiple Sclerosis PHASE4 COMPLETED 2025-12-23 SUNY Buffalo, Buffalo, New Yor... More >>k, 14203, United States Less <<
NCT05265728 Multiple Sclerosis, Relapsing-... More >>Remitting Less << PHASE3 TERMINATED 2024-05-27 Juntendo University Hospital, ... More >>Bunkyo-ku, 113-8431, Japan|Chiba University Hospital, Chiba-shi, 260-8677, Japan|St.Marianna University Hospital, Kawasaki-shi, 216-8511, Japan|National Center of Neurology and Psychiatry, Kodaira-shi, 187-8551, Japan|Kansai Medical University Medical Center, Moriguchi-shi, 570-8507, Japan|Tokyo Metropolitan Hospital Organization Tokyo Metropolitan Ebara Hospital, Ota-ku, 145-0065, Japan|The Kitasato Institute Kitasato University Hospital, Sagamihara-shi, 252-0375, Japan|National Hospital Organization Hokkaido Medical Center, Sapporo-shi, 063-0005, Japan|Tohoku Medical and Pharmaceutical University Hospital, Sendai-shi, 983-8512, Japan|Osaka University Hospital, Suita-shi, 565-0871, Japan|University of Tsukuba Hospital, Tsukuba-shi, 305-8576, Japan|Tokyo Women's Medical University Yachiyo Medical Center, Yachiyo-shi, 276-8524, Japan Less <<
NCT04832399 Relapsing Remitting Multiple S... More >>clerosis Less << COMPLETED 2023-10-02 Research Site, Amadora, 2720-2... More >>76, Portugal|Research Site, Angra do Heroismo, 9700-049, Portugal|Research Site, Aveiro, 3810-164, Portugal|Research Site, Braga, 4710-243, Portugal|Research Site, Coimbra, 3004-561, Portugal|Research Site, Faro, 8000-386, Portugal|Research Site, Funchal, 9000-177, Portugal|Research Site, Guimaraes, 4835-044, Portugal|Research Site, Leiria, 2410-197, Portugal|Research Site, Lisboa, 1649-028, Portugal|Research Site, Loures, 2674-514, Portugal|Research Site, Matosinhos, 4450-021, Portugal|Research Site, Penafiel, 4564-007, Portugal|Research Site, Porto, 4200-319, Portugal|Research Site, Santa Maria da Feira, 4520-220, Portugal|Research Site, Setubal, 2910-446, Portugal|Research Site, Viana do Castelo, 4904-858, Portugal|Research Site, Vila Nova de Gaia, 4434-502, Portugal Less <<
NCT04964700 Multiple Sclerosis UNKNOWN 2022-06-01 Multiple Sclerosis Center of N... More >>ortheastern New York, P.C., Latham, New York, 12110, United States Less <<
NCT00276172 Multiple Sclerosis PHASE3 COMPLETED 2025-01-06 Performed at only C-1801, C-18... More >>02, and C-1803 sites globally. No general public enrollment. Biogen Idec is located in, Cambridge, Massachusetts, 02142, United States Less <<
NCT00744679 Multiple Sclerosis PHASE4 COMPLETED 2025-12-08 Research Site, Latham, New Yor... More >>k, United States Less <<
NCT05304520 Relapsing-Remitting Multiple S... More >>clerosis (RRMS) Less << COMPLETED 2024-04-30 Neurozentrum am K?nigsplatz Au... More >>gsburg; Dres. Müller und Schmid, Augsburg, Germany|Praxis Dr. Sch?ll, Bad Homburg, Germany|Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany|Neurologische Praxis Dr. med. Boris-Alexander Kallmann, Bamberg, Germany|Marianne-Strau?-Klinik Starnberg, Berg, Germany|Neurologie am Mexikoplatz, Berlin, Germany|Neurologie im Tempelhofer Hafen Berlin, Berlin, Germany|Neurologisches Facharztzentrum Dr. Masri & Kollegen, Berlin, Germany|NFZB Neurologisches Facharztzentrum Berlin, Berlin, Germany|Praxis für Neurologie/Dr. med. Martin Delf, Berlin, Germany|Katholisches Klinikum Bochum gGmbH, Bochum, Germany|Praxis Dres. Kausch/Lippert, Bogen, Germany|Neurologische Studiengesellschaft Bonn GbR, Bonn, Germany|MVZ Daun GmbH, Daun, Germany|Neurologie Dillingen, Dillingen, Germany|Gemeinschaftspraxis für Neurologie, Düsseldorf, Germany|Praxis Dr. Hartmann, Eltville, Germany|Neuro Centrum science GmbH, Erbach, Germany|Universit?tsklinikum Erlangen, Neurolische Klinik, Erlangen, Germany|med.ring GmbH, Essen, Germany|NeuroDot GmbH, Grevenbroich, Germany|GP Dr. med. Wolfgang Klostermann/ Dr. med. Samir Al-Boutros, Hagen, Germany|Krankenhaus Martha-Maria Halle-D?lau; Klinik für Neurologie, Halle (Saale), Germany|Universit?tsklinikum Jena, Hans-Berger-Klinik für Neurologie, Jena, Germany|Praxis Dr. Fischer, Lappersdorf, Germany|Neurokomm - Gesellschaft für Studien und Kommunikation, Mannheim, Germany|NPS Neurologisch Psychiatrische Studiengesellschaft, Mannheim, Germany|GP Neurologie am Preu?enmuseum/ Martina Lorenz/ Dr. med. Birgit Erker, Minden, Germany|Landesklinkum Mistelbach-G?nserndorf, Abteilung Neurologie, Mistelbach, Germany|Hygieia Pharmakologisches Studienzentrum Chemnitz GmbH, Au?enstelle Mittweida, Mittweida, Germany|Amperklinikum München Haar, München, Germany|CODAST, München, Germany|Neurologie Neu-Ulm, Neu-Ulm, Germany|Bergmann.Consult, Neuburg, Germany|Neurozentrum Prien, Prien am Chiemsee, Germany|EMSA, Singen, Germany|NeuroSinsheim, Sinsheim, Germany|Nervenfach?rztliche GP, Ulm, Germany|Neuropraxis München Süd, Unterhaching, Germany|Praxis Dr. Krause, Wolfratshausen, Germany Less <<
NCT05236777 Multiple Sclerosis RECRUITING 2025-04-30 Fakultní nemocnice Brno, Brno,... More >> Czechia|Fakultní nemocnice u sv. Anny v Brně, Brno, Czechia|Fakultní nemocnice Hradec Králové, Hradec Králové, Czechia|Nemocnice Jihlava, Jihlava, Czechia|Fakultní nemocnice Olomouc, Olomouc, Czechia|Fakultní nemocnice v Ostravě, Ostrava, Czechia|Nemocnice Pardubického kraje, Pardubice, Czechia|Fakultní nemocnice v Plzni, Pilsen, Czechia|Fakultní nemocnice Královské Vinohrady v Praze, Prague, Czechia|Fakultní nemocniceMotol v Praze, Prague, Czechia|Fakultní Thomayerova nemocnice v Praze v Kr?i, Prague, Czechia|V?eobecná fakultní nemocnice v Praze, Prague, Czechia|Nemocnice Teplice, Teplice, Czechia|Krajská nemocnice T. Bati ve Zlíně, Zlín, Czechia|Nemocnice ?eské Budějovice, ?eské Budějovice, Czechia Less <<
NCT00942214 Multiple Sclerosis PHASE4 COMPLETED 2025-03-11 service de neurologie, h?pital... More >> Purpan, Toulouse, 31059, France Less <<
NCT05532163 Multiple Sclerosis, Relapsing-... More >>Remitting Less << PHASE4 TERMINATED 2023-10-09 Neurologische Praxis Dr. med. ... More >>Boris-Alexander Kallmann, Bamberg, 96052, Germany|Neurologische Studiengesellschaft Bonn GbR, Bonn, 53111, Germany Less <<
NCT05925049 Multiple Sclerosis ACTIVE_NOT_RECRUITING 2025-12-31 Research Site, Cambridge, Mass... More >>achusetts, 02142, United States Less <<
NCT01077466 Primary Progressive Multiple S... More >>clerosis|Secondary Progressive Multiple Sclerosis Less << PHASE2 COMPLETED 2025-01-12 Danish Multiple Sclerosis Cent... More >>er, Section 2082, Rigshospitalet, Copenhagen, 2100, Denmark Less <<
NCT03811886 Pulmonary Metastatic Osteosarc... More >>oma (pOS) Less << PHASE1|PHASE2 WITHDRAWN 2026-10-01 University Hospitals Cleveland... More >> Medical Center, Case Comprehensive Cancer Center, Cleveland, Ohio, 44106, United States Less <<
NCT03516526 Multiple Sclerosis PHASE4 COMPLETED 2019-07-01 OLVG, Amsterdam, Netherlands|V... More >>U medical center, Amsterdam, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Erasmus medical center, Rotterdam, Netherlands|St. Antonius Hospital, Utrecht, Netherlands Less <<
 

Historical Records

Categories